dihydroxyphenylalanine has been researched along with Cortical Lewy Body Disease in 5 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Excerpt | Relevance | Reference |
---|---|---|
"Braak's staging concept of Lewy body disease pathogenesis is based on a spatiotemporal sequence of alpha-synuclein deposition, with autonomic nervous system involvement before synucleinopathy in substantia nigra neurons." | 3.78 | Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. ( Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klein, JC | 1 |
Eggers, C | 1 |
Kalbe, E | 1 |
Weisenbach, S | 1 |
Hohmann, C | 1 |
Vollmar, S | 1 |
Baudrexel, S | 1 |
Diederich, NJ | 1 |
Heiss, WD | 1 |
Hilker, R | 1 |
Salazar, G | 1 |
Cuello, D | 1 |
Fragoso, M | 1 |
Benlloc, L | 1 |
Goldstein, DS | 1 |
Holmes, C | 1 |
Sewell, L | 1 |
Park, MY | 1 |
Sharabi, Y | 1 |
Hu, XS | 1 |
Okamura, N | 1 |
Arai, H | 1 |
Higuchi, M | 1 |
Matsui, T | 1 |
Tashiro, M | 1 |
Shinkawa, M | 1 |
Itoh, M | 1 |
Ido, T | 1 |
Sasaki, H | 1 |
Hisanaga, K | 1 |
Suzuki, H | 1 |
Tanji, H | 1 |
Mochizuki, H | 1 |
Iwasaki, Y | 1 |
Sato, N | 1 |
Jin, K | 1 |
5 other studies available for dihydroxyphenylalanine and Cortical Lewy Body Disease
Article | Year |
---|---|
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; | 2010 |
Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dihydroxyphenylalanine | 2011 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; | 2012 |
18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Kinetics; Lewy B | 2000 |
Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonanc | 2001 |